Enzon Pharma (ENZN) – Press Releases
-
Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon’s CFO, to Assume Position of CEO and Remain CFO
-
Enzon Pharmaceuticals Announces Results of Rights Offering
-
Enzon Pharmaceuticals Announces Key Dates for Rights Offering
-
Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual Meeting
-
Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders
-
Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its NOL Assets and Shareholder Value
-
OTC Markets Group Welcomes Enzon Pharmaceuticals, Inc. to OTCQX
-
Annual Changes to the NASDAQ Biotechnology Index
Back to ENZN Stock Lookup